Zobrazeno 1 - 10
of 70
pro vyhledávání: '"N, Salesi"'
Autor:
A, De Cesare, C, Di Cristofano, A R, Di Filippo, N, Salesi, M, Spaziani, M, Picchio, E, Spaziani
Primary squamous cell carcinoma of the thyroid (PSCCT) is a rare malignant disease with rapid fatal prognosis. The onset is generally characterized by sudden bilateral latero-cervical lymphadenopathy. The Authors report patient of 58-year-old who ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::949391d653058e69318a3ac02e8fbfb1
http://hdl.handle.net/11573/1305744
http://hdl.handle.net/11573/1305744
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Liposarcomas are the most common type of sarcomas arising in the retroperitoneum. Retroperitoneal lipomas are extremely rare. They should be distinguished from well-differentiated liposarcomas in order to provide the appropriate treatment. A 53-years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::780cc3dc1f073daada7416146512cfab
http://hdl.handle.net/11573/960108
http://hdl.handle.net/11573/960108
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of experimentalclinical cancer research : CR. 26(4)
Metastases to the bones of the hands and feet (acrometastases) represent an uncommon site of recurrence of renal cell carcinoma (RCC). Although challenging, the prompt recognition of solitary acrometastasis from RCC is of crucial importance, since su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::658bfcc728553541c6b88105b8470521
https://pubmed.ncbi.nlm.nih.gov/18365558
https://pubmed.ncbi.nlm.nih.gov/18365558
Autor:
Daniele Bernardi, M. Mencoboni, Antonio Frassoldati, P. Tagliaferri, T. Raggi, Teresa Gamucci, Giovanni Rosti, G. Bonciarelli, R. Maisano, N. Salesi, E. Scelzi
Publikováno v:
Annals of Oncology. 26:vi121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e7a039f8bf236adb4f8f30cdb2ae43b
https://doi.org/10.1093/annonc/mdv346.29
https://doi.org/10.1093/annonc/mdv346.29
Autor:
A, Fabi, N, Salesi, B, Di Cocco, A, Vidiri, P, Visca, A, Pace, C, Carapella, U, De Paula, A, Mirri, F, Cognetti
Publikováno v:
Journal of experimentalclinical cancer research : CR. 24(3)
Choroid plexus carcinoma is a rare primary brain neoplasm arising from epithelial differentiated tissue, originating from the choroids plexus of the ventricles and, in 90% of the cases, in the lateral and fourth ventricles. This neoplasm is seen main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7477fcdece859e7f8e4e793bdff1cbbc
https://pubmed.ncbi.nlm.nih.gov/16270538
https://pubmed.ncbi.nlm.nih.gov/16270538
Publikováno v:
Minerva ginecologica. 55(4)
Many circulating markers are already in clinical practice and in experimental use for the diagnosis, therapeutic monitoring, and in the follow-up of ovarian cancer. The cancer antigen-125 (CA-125) has shown to be useful in epithelial ovarian cancer,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95f92524d8d2c97869a760e34baff8cd
https://pubmed.ncbi.nlm.nih.gov/14581857
https://pubmed.ncbi.nlm.nih.gov/14581857
Publikováno v:
Minerva medica. 94(2)
The therapy of chronic myeloid leukemia, characterized by the presence of the Philadelphia chromosome in the clonal hematopoietic stem cells, has changed dramatically in the last years with the development of a specific inhibitor of the BCR-ABL tyros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f71ba7a5ec720c8d1c9c846279bcca1
https://pubmed.ncbi.nlm.nih.gov/12858155
https://pubmed.ncbi.nlm.nih.gov/12858155
Autor:
M.S. Rosati, M. Muenzberg, H. Barker, Samir G. Agrawal, Pere Gascón, N. Salesi, K. Verpoort, Matthew Turner, H. Tesch
Publikováno v:
Annals of Oncology. 23:ix502-ix503
Introduction Biosimilar versions of G-CSF have been approved for the prevention of chemotherapy-induced neutropenia since 2008, with approval being based on comparable efficacy, safety and quality with the originator G-CSF. Early clinical experience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efe2ce754707f954f22e710ca8f549aa
https://doi.org/10.1016/s0923-7534(20)34101-6
https://doi.org/10.1016/s0923-7534(20)34101-6